Overview
Sara Lear practices practicing medicine in Cambridge, United Kingdom.
Her clinical expertise encompasses Properdin Deficiency, Severe Acute Respiratory Syndrome (SARS), Membranoproliferative Glomerulonephritis, and COVID-19.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sara E. Lear
Is Sara E. Lear a top-rated expert for Properdin Deficiency?
MediFind is an objective health platform that identifies experts based on real-world data. Sara E. Lear is classified as an Experienced expert for Properdin Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sara E. Lear participate in research or clinical trials?
Yes. Sara E. Lear has published 11 articles and abstracts on conditions like Properdin Deficiency. You can view a list of Sara E. Lear's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Ms. Lear isExperienced. Learn about COVID-19.
- Membranoproliferative Glomerulonephritis
- Properdin DeficiencyMs. Lear isExperienced. Learn about Properdin Deficiency.
- Severe Acute Respiratory Syndrome (SARS)